Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Clene Inc
(NQ:
CLNN
)
5.160
-0.040 (-0.77%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clene Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Clene Inc. (NASDAQ: CLNN) Reports Improved Survival Status in ALS Patients Treated with CNM-Au8(R) on Follow-Up Analysis; Announces Peer-Reviewed Study
October 30, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 25, 2023
Via
Benzinga
Clene Inc. (NASDAQ: CLNN) Announces Four-Year Grant to Support Expanded Access Protocol for CNM-Au8 From NINDS
October 25, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) ‘Innovates’ Investigational Drug with Patented Nanotechnology
October 17, 2023
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Is ‘One to Watch’
September 28, 2023
Via
Investor Brand Network
Expert Ratings for Clene
September 21, 2023
Via
Benzinga
Where Clene Stands With Analysts
August 14, 2023
Via
Benzinga
Clene Inc. (NASDAQ: CLNN) Applies Patented Nanotechnology to Development of CNM-Au8(R), its Investigational Drug for ALS
October 16, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Featured in Latest Episode of The Bell2Bell Podcast
October 10, 2023
Via
Investor Brand Network
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Intraday Session
October 05, 2023
Via
Benzinga
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces $45.1M NINDS Grant to Support Expanded Access Protocol for CNM-Au8(R) in ALS
October 05, 2023
Via
Investor Brand Network
Why Clene Shares Are Nosediving
June 16, 2023
Clene Inc. (NASDAQ: CLNN) shares are trading lower by 13.81% to $0.90 Friday morning after the company announced pricing of a $40 million public offering.
Via
Benzinga
Where Clene Stands With Analysts
June 16, 2023
Via
Benzinga
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Investigational Drug Focus of Study Published in Peer-Reviewed Journal
September 28, 2023
Via
Investor Brand Network
Clene's Neurogenerative Candidate Shows Potential For Improved Long-Term Survival
September 25, 2023
Clene Inc. (NASDAQ: CLNN) released long-term follow-up data for patients treated with CNM-Au8 30mg for up to 133 weeks in the
Via
Benzinga
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Releases Significant Long-Term Survival Improvement Data from ALS Trial
September 25, 2023
Via
Investor Brand Network
Expert Ratings for Clene
May 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 25, 2023
Via
Benzinga
Clene And 2 Other Stocks Under $3 Insiders Are Aggressively Buying
June 28, 2023
The Dow Jones closed higher by over 200 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces $40M Public Offering
June 22, 2023
Via
Investor Brand Network
Uber To Rally Around 55%? Here Are 10 Other Analyst Forecasts For Wednesday
June 21, 2023
Rosenblatt boosted the price target for Lumentum Holdings Inc. (NASDAQ: LITE) from $48 to $67. Rosenblatt analyst Mike Genovese maintained a Neutral rating. Lumentum shares fell 1.3% to $60.56 in...
Via
Benzinga
Nasdaq Down 80 Points; US Consumer Sentiment Surges To 4-Month High In June
June 16, 2023
U.S. stocks traded lower toward the end of trading, with Nasdaq Compsoite dropping around 80 points on Friday. The Dow traded down 0.24% to 34,324.18 while the NASDAQ fell 0.59% to 13,701.06. The S&P...
Via
Benzinga
Clene's CNM-Au8 Shows Significant Reduction In Neurodegenerative Biomarker, Raises $40M Via Equity
June 16, 2023
Clene Inc (NASDAQ: CLNN) reported new data demonstrating a statistically significant reduction of plasma neurofilament light chain (NfL) levels for CNM-Au8 treated participants compared to placebo...
Via
Benzinga
Crude Oil Rises; Adobe Posts Upbeat Results
June 16, 2023
U.S. stocks traded slightly higher midway through trading, with Dow Jones gaining around 20 points on Friday. The Dow traded up 0.06% to 34,428.13 while the NASDAQ rose 0.05% to 13,789.23. The S&P 500,...
Via
Benzinga
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 16, 2023
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 16, 2023
Via
Benzinga
Why Clene Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
June 16, 2023
Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) shares gained 192.8% to $0.2427 in pre-market trading. Evelo Biosciences was granted U.S. patent #11672834 for "Prebiotic Compositions And Methods Of Use...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 09, 2023
Via
Benzinga
Gilead Sciences To Rally Around 28%? Here Are 10 Other Analyst Forecasts For Tuesday
May 16, 2023
Morgan Stanley raised the price target for DraftKings Inc. (NASDAQ: DKNG) from $23 to $25. Morgan Stanley analyst Stephen Grambling maintained an Overweight rating. DraftKings shares fell 0.2% to close...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.